A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study.

A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study.

BACKGROUND: Controversy still exists regarding whether alendronate (ALN) use increases the risk of esophageal cancer or breast cancer. METHODS: This paper explores the possible association between the use of oral ALN in osteoporosis patients and subsequent cancer risk using the National Health Insur...

Full description

Bibliographic Details
Main Authors: Wen-Yuan Lee, Li-Min Sun, Ming-Chia Lin, Ji-An Liang, Shih-Ni Chang, Fung-Chang Sung, Chih-Hsin Muo, Chia-Hung Kao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3534103?pdf=render

Internet

http://europepmc.org/articles/PMC3534103?pdf=render

Similar Items